Italian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
ACS Chemical Neuroscience 2020-Jan

Potential neuroprotective effect of the HMGB1 inhibitor Glycyrrhizin in neurological disorders.

Solo gli utenti registrati possono tradurre articoli
Entra registrati
Il collegamento viene salvato negli appunti
Yam Paudel
Efthalia Angelopoulou
Bridgette Semple
Christina Piperi
Iekhsan Othman
Mohd Shaikh

Parole chiave

Astratto

Glycyrrhizin (Glycyrrhizic Acid), a bioactive triterpenoid saponin found in Glycyrrhiza glabra, has been used for a long time in traditional medicine. Glycyrrhizin possesses a plethora of pharmacological activities including anti-inflammatory, antioxidant, anti-microbial and anti-ageing potential. It is a well-established pharmacological inhibitor of high mobility group box 1 (HMGB1), a ubiquitous protein with pro-inflammatory cytokine-like activity. HMGB1 contributes to an array of inflammatory diseases when released extracellularly, primarily via the activation of cell signaling upon binding to receptor for advanced glycation end products (RAGE) and toll-like receptor 4 (TLR4). HMGB1 neutralization strategies have demonstrated disease-modifying outcomes against several pre-clinical models of neurological disorders, mainly through inhibition of HMGB1 expression and release. In this review, we aim to enlighten the therapeutic potential of glycyrrhizin against different neurological disorders. Current research studies demonstrate the therapeutic potential of glycyrrhizin against several HMGB1-mediated pathological conditions including Traumatic brain injury, Neuroinflammation and associated conditions, Epileptic seizures, Alzheimer's disease and related pathology, Parkinson's disease and Multiple sclerosis. Glycyrrhizin's effects in neurological disorders are mainly attributed to attenuation of neuronal damage by inhibiting HMGB1 expression and translocation as well as by downregulating expression of inflammatory cytokines. Current scientific evidence indicates that glycyrrhizin might be a promising therapeutic alternative that could overcome the limitations of current treatment strategy against these neurological disorders discussed herein mainly via halting disease progression. However, future research is warranted for deeper exploration of the precise underlying molecular mechanism as well as for clinical translation.

Unisciti alla nostra
pagina facebook

Il database di erbe medicinali più completo supportato dalla scienza

  • Funziona in 55 lingue
  • Cure a base di erbe sostenute dalla scienza
  • Riconoscimento delle erbe per immagine
  • Mappa GPS interattiva - tagga le erbe sul luogo (disponibile a breve)
  • Leggi le pubblicazioni scientifiche relative alla tua ricerca
  • Cerca le erbe medicinali in base ai loro effetti
  • Organizza i tuoi interessi e tieniti aggiornato sulle notizie di ricerca, sperimentazioni cliniche e brevetti

Digita un sintomo o una malattia e leggi le erbe che potrebbero aiutare, digita un'erba e osserva le malattie ei sintomi contro cui è usata.
* Tutte le informazioni si basano su ricerche scientifiche pubblicate

Google Play badgeApp Store badge